Français
= Identification of Sunlenca:
| No description |
Search images on Google Product Monograph
Active Ingredients:
- lenacapavir (lenacapavir sodium), 300 MG
DIN: 02532468
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Schedule: Prescription
Company: GILEAD SCIENCES CANADA INC
ATC:
- J05 - ANTIVIRALS FOR SYSTEMIC USE (ATC, WHO, Wiki)
- J05A - DIRECT ACTING ANTIVIRALS (ATC, WHO)
- J05AX - Other antivirals (ATC, WHO)
- J05AX31 - LENACAPAVIR (WHO)
